|
1
|
Lissidini G, Mule A, Santoro A, Papa G,
Nicosia L, Cassano E, Ashoor AA, Veronesi P, Pantanowitz L, Hornick
JL and Rossi ED: Malignant phyllodes tumor of the breast: A
systematic review. Pathologica. 114:111–120. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rakha EA and Ellis IO: Phyllodes Tumor of
the Breast. In: Textbook of Uncommon Cancer. Raghavan D, Blanke CD,
Johnson DH, Moots PL, Reaman GH, Rose PG and Sekeres MA (eds).
Wiley-Blackwell, Hoboken, NJ, p. 243-56, 2012.
|
|
3
|
Tan BY, Acs G, Apple SK, Badve S,
Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V, et
al: Phyllodes tumours of the breast: A consensus review.
Histopathology. 68:5–21. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tan PH, Ellis I, Allison K, Brogi E, Fox
SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, et al: The
2019 World Health Organization classification of tumours of the
breast. Histopathology. 77:181–185. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yu CY, Huang TW and Tam KW: Management of
phyllodes tumor: A systematic review and meta-analysis of
real-world evidence. Int J Surg. 107(106969)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tan PH, Thike AA, Tan WJ, Thu MM, Busmanis
I, Li H, Chay WY and Tan MH: Phyllodes Tumour Network Singapore.
Predicting clinical behaviour of breast phyllodes tumours: A
nomogram based on histological criteria and surgical margins. J
Clin Pathol. 65:69–76. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bogach J, Shakeel S, Wright FC and Hong
NJL: Phyllodes Tumors: A scoping review of the literature. Ann Surg
Oncol. 29:446–459. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lim RS, Cordeiro E, Lau J, Lim A, Roberts
A and Seely J: Phyllodes tumors-the predictors and detection of
recurrence. Can Assoc Radiol J. 72:251–257. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lashen AG, Toss MS, Ghannam SF, Makhlouf
S, Green A, Mongan NP and Rakha E: Expression, assessment and
significance of Ki67 expression in breast cancer: An update. J Clin
Pathol. 76:357–364. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Finkelman BS, Zhang H, Hicks DG and Turner
BM: The Evolution of Ki-67 and Breast Carcinoma: Past observations,
present directions, and future considerations. Cancers (Basel).
15(808)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Boninsegna L, Panzuto F, Partelli S,
Capelli P, Delle Fave G, Bettini R, Pederzoli P, Scarpa A and
Falconi M: Malignant pancreatic neuroendocrine tumour: Lymph node
ratio and Ki67 are predictors of recurrence after curative
resections. Eur J Cancer. 48:1608–1615. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
La Rosa S: Diagnostic, prognostic, and
predictive role of Ki67 proliferative index in neuroendocrine and
endocrine neoplasms: Past, present, and future. Endocr Pathol.
34:79–97. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yamaguchi T, Fujimori T, Tomita S,
Ichikawa K, Mitomi H, Ohno K, Shida Y and Kato H: Clinical
validation of the gastrointestinal NET grading system: Ki67 index
criteria of the WHO 2010 classification is appropriate to predict
metastasis or recurrence. Diagn Pathol. 8(65)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tse GM, Niu Y and Shi HJ: Phyllodes tumor
of the breast: An update. Breast Cancer. 17:29–34. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Love J, Selker R, Marsman M, Jamil T,
Dropmann D, Verhagen J, Ly A, Gronau QF, Šmíra M, Epskamp S, et al:
JASP: Graphical statistical software for common statistical
designs. Journal of Statistical Software. 88:1–17. 2019.
|
|
18
|
Kuijper A, de Vos RA, Lagendijk JH, van
der Wall E and van Diest PJ: Progressive deregulation of the cell
cycle with higher tumor grade in the stroma of breast phyllodes
tumors. Am J Clin Pathol. 123:690–698. 2005.PubMed/NCBI
|
|
19
|
Kuijper A, van der Groep P, van der Wall E
and van Diest PJ: Expression of hypoxia-inducible factor 1 alpha
and its downstream targets in fibroepithelial tumors of the breast.
Breast Cancer Res. 7:R808–R818. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Chan YJ, Chen BF, Chang CL, Yang TL and
Fan CC: Expression of p53 protein and Ki-67 antigen in phyllodes
tumor of the breast. J Chin Med Assoc. 67:3–8. 2004.PubMed/NCBI
|
|
21
|
Niezabitowski A, Lackowska B, Rys J,
Kruczak A, Kowalska T, Mitus J, Reinfuss M and Markiewicz D:
Prognostic evaluation of proliferative activity and DNA content in
the phyllodes tumor of the breast: Immunohistochemical and flow
cytometric study of 118 cases. Breast Cancer Res Treat. 65:77–85.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shpitz B, Bomstein Y, Sternberg A, Klein
E, Tiomkin V, Kaufman A, Groisman G and Bernheim J:
Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of
the breast in correlation with clinical and morphologic features. J
Surg Oncol. 79:86–92. 2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yonemori K, Hasegawa T, Shimizu C, Shibata
T, Matsumoto K, Kouno T, Ando M, Katsumata N and Fujiwara Y:
Correlation of p53 and MIB-1 expression with both the systemic
recurrence and survival in cases of phyllodes tumors of the breast.
Pathol Res Pract. 202:705–712. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sain B, Gupta A, Ghose A, Halder S,
Mukherjee V, Bhattacharya S, Mondal RR, Sen AN, Saha B, Roy S and
Boussios S: Clinico-Pathological factors determining recurrence of
phyllodes tumors of the breast: The 25-year experience at a
tertiary cancer centre. J Pers Med. 13(866)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
McCarthy E, Kavanagh J, O'Donoghue Y,
McCormack E, D'Arcy C and O'Keeffe SA: Phyllodes tumours of the
breast: Radiological presentation, management and follow-up. Br J
Radiol. 87(20140239)2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chng TW, Lee JY, Lee CS, Li H, Tan MH and
Tan PH: Validation of the Singapore nomogram for outcome prediction
in breast phyllodes tumours: An Australian cohort. J Clin Pathol.
69:1124–1126. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Choi JE, Kang SH, Tan PH and Bae YK:
Recurrence prediction for breast phyllodes tumours: Validation of
the Singapore nomogram in Korean women. J Clin Pathol. 75:159–163.
2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nishimura R, Tan PH, Thike AA, Tan MH,
Taira N, Li HH and Ohsumi S: Utility of the Singapore nomogram for
predicting recurrence-free survival in Japanese women with breast
phyllodes tumours. J Clin Pathol. 67:748–750. 2014.PubMed/NCBI View Article : Google Scholar
|
